Client is a biopharmaceutical company that develops medicines in areas of unmet need.
Issues related to reforming and increasing transparency within the 340B Drug Pricing Program. Issues related to Pharmacy Benefit Manager reform included in S. 1339 - Pharmacy Benefit Manager Reform Act, H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023, S.127 PBM Transparency Act of 2023, H.R. 4507 -Transparency in Coverage Act of 2023, S. 1967 - PBM Act. S.1375/H.R. 830 HELP Copays Act Access and reimbursement of drugs in Medicare Parts B and D. Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
ALANNA TEMME JOHN MCMANUS ALANNA TEMME (LD, Rep. Jon Porter) JOHN MCMANUS
LD, Rep. Jon Porter